Conservest Capital Advisors’s AbbVie ABBV Stock Holding History

Conservest Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$349K	Buy	1,387 +91	+7%	+$19.6K	0.03%	109
2026 Q1	$282K	Buy	1,296 +51	+4%	+$11.3K	0.03%	109
2025 Q4	$285K	Sell	1,245 -17	-1%	-$3.87K	0.03%	104
2025 Q3	$292K	Buy	1,262 +4	+0.3%	+$815	0.03%	102
2025 Q2	$233K	Buy	1,258 +57	+5%	+$10.6K	0.02%	115
2025 Q1	$252K	Buy	1,201 +2	+0.2%	+$389	0.03%	98
2024 Q4	$213K	Buy	1,199 +4	+0.3%	+$735	0.02%	103
2024 Q3	$218K	Hold	1,195	–	–	0.02%	101
2024 Q2	$218K	Hold	1,195	–	–	0.02%	100
2024 Q1	$218K	Buy	+1,195	New	+$206K	0.02%	101
2022 Q3	–	Sell	-1,475	Closed	-$226K	–	90
2022 Q2	$226K	Buy	+1,475	New	+$225K	0.03%	81

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Conservest Capital Advisors's ABBV Position: Q2 2026 in Review

Conservest Capital Advisors increased its AbbVie (ABBV) stake by 7% in Q2 2026, buying an estimated $19.6K and bringing the position to 1,387 shares worth $349K. The position accounts for 0.03% of the portfolio, ranked #109.

Conservest Capital Advisors first reported a position in ABBV in Q2 2022 and has held it in 11 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Conservest Capital Advisors held 1,387 shares of AbbVie worth $349K as of Q2 2026.
Conservest Capital Advisors bought 91 AbbVie shares in Q2 2026, an estimated $19.6K.
AbbVie made up 0.03% of Conservest Capital Advisors's portfolio in Q2 2026, its #109 holding.
Conservest Capital Advisors first reported a position in AbbVie in Q2 2022 and has held it in 11 quarters since.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Conservest Capital Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.